← Browse by Condition
Medical Condition
myopia progression
Total Trials
2
Recruiting Now
2
Trial Phases
Phase 3
ClinicalMetric tracks all active clinical trials for myopia progression sourced from ClinicalTrials.gov. Each listing includes the NCT identifier, current recruitment status, phase, primary endpoints, sponsor, estimated enrollment, and participating countries — updated daily as new studies open and status changes.
- Recruiting trials currently enrolling participants, with eligibility criteria and age requirements
- Phase 1–4 studies from early safety trials to post-marketing surveillance
- NIH, pharmaceutical sponsor, and academic medical center studies worldwide
- AI-powered plain-language summary available for every trial listing
Trial Phases
Phase 3 1
Top Sponsors
1 trial
1 trial
Recruiting Clinical Trials
NCT07329777 Phase 3
Recruiting
Atropine in the Treatment of Myopia Study in Malaysia
Enrollment
144 pts
Location
Malaysia
Sponsor
IDB VisionCare SDN BHD
NCT07229365
Recruiting
Children's Viewing Behavior
Enrollment
20 pts
Location
United States
Sponsor
SightGlass Vision, Inc.
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology